John Davies

John Davies appears in our data through filings on Gemina Laboratories Ltd. shares, published by SEDI. In total, 4 filings cover trades dated from 1 February 2021 to 6 May 2022.

No open-market sale appears; the market trades are 3 purchases worth €4,966. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2022 to date brings 3 purchases and no sales.

Half of the purchases are above €646 and half below. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.

On 6 May 2022 came the latest disclosure, an open-market purchase for €3,728 in Gemina Laboratories Ltd. Typically, a trade is published a median of 3 days after it takes place. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.